Asset Chemist launches first website in relation to high value injectionsfor the treatment of osteoarthritis and prostate cancer
February 26, 2007 (Press Release) --
Asset Chemist has launched the webs first website dedicated specifically to the treatment of osteoarthritis and prostate cancer.
Alex Blake Asset Chemist's Business Development manager said; "On the web there are dedicated websites for erectile dysfunction and obesity and the like, but in relation to the daily needs of patients, they would have to hope that one of the so-called Canadian Pharmacies stock it." " What we are offering is the opportunity is the purchase at low cost injections which are for the treatment of acute pain and prostate cancer."
Asset Chemist through its portal www.assetchemist.org.uk, offers patients Zoladex, Synvisc, Lupron, Hyalgan, Orthovisc, Fermathron and Ostenil at the best prices available on the web
Alex Blake Asset Chemist's Business Development manager said; "On the web there are dedicated websites for erectile dysfunction and obesity and the like, but in relation to the daily needs of patients, they would have to hope that one of the so-called Canadian Pharmacies stock it." " What we are offering is the opportunity is the purchase at low cost injections which are for the treatment of acute pain and prostate cancer."
Asset Chemist through its portal www.assetchemist.org.uk, offers patients Zoladex, Synvisc, Lupron, Hyalgan, Orthovisc, Fermathron and Ostenil at the best prices available on the web
Email
Print
SPAM
